WRBY Stock Analysis: Buy, Sell, or Hold?

WRBY - Warby Parker Inc.

OPHTHALMIC GOODS
$26.03
-0.96 (-3.56%) ▼
5d: -1.33%
30d: +6.24%
90d: +7.65%
BUY
MODERATE Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 06, 2026
Smart Money Distribution

None View Scanner →

Strength: 5.9/10

Get Alerted When WRBY Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

💡
Bottom Line:
💡 BUY OPPORTUNITY: WRBY shows positive signals but monitor for confirmation. Market pricing in 1.2% decline. Moderate conviction.
See Forward Earnings Fair Value & Price Prediction →

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$32.33
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$20.07
Trading above historical range

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: WRBY is currently trading at $26.03, which is considered slightly high relative to its 30-day fair value range of $24.02 to $26.71. The stock's valuation (Forward PE: 40.6) is in line with its historical norms (42.1). Remarkably, the market is currently pricing in an annual earnings decline of 1.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, WRBY is showing sideways momentum. The price is approaching resistance at $26.36. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. Short-term momentum is weak, with the stock down 3.6% recently.

Market Sentiment: WRBY has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $29.92 (+10.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position SLIGHTLY HIGH
Historical Trading Range $24.02 - $26.71
Company Quality Score 60/100 (BUY)
Volume Confirmation HIGH
Confidence Score 69.0%

All Signals

  • BULLISH: Strong technical setup (75/100)
  • BULLISH: High volume confirmation
  • BEARISH: Downward momentum (-3.6%)
  • BULLISH: Trading below Wall St target ($29.92)

Trading Range Analysis

30-Day Trading Range $24.02 - $26.71
Current vs Trading Range SLIGHTLY HIGH

Support & Resistance Levels

Support Level $22.13
Resistance Level $26.36
Current Trend Sideways
Technical data as of Jun 9, 2026

Fundamental Context

Forward P/E (Next Year Est.) 40.65
Wall Street Target $29.92 (+10.8%)
Revenue Growth (YoY) 8.3%
Earnings Growth (YoY) -9.6%
Profit Margin 0.1%
Valuation Discount vs History -1.2% cheaper
PE vs Historical 40.7 vs 42.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -1.2% (market-implied from PE analysis)
1-Year Target $26.67 (-1%)
2-Year Target $26.35 (-2%)
3-Year Target $26.03 (-4%)
3-Yr Target (if PE normalizes) (PE: 41→42) $26.96 (0%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 40.6, Growth: 39.3%) $73.03 (+171%)
Base: (SPY PE: 21.8, Growth: 39.3%) $39.13 (+45%)
Bear: (PE: 18.5, Growth: 39.3%) $33.26 (+23%)
📈 Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (57x PE), but valuation improves significantly next year (41x PE) as earnings recover.
Forward PE: 56.50 | Forward EPS (Implied): $0.48
Bull Case $32.59 (+21%)
Analyst growth 15.0%, PE expands to 59.3
Base Case $26.99 (0%)
Market implied 0.0%, PE stable at 56.5
Bear Case $20.65 (-24%)
Severe decline -15.0%, PE contracts to 50.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡 Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 40.6 to 42.1
Stabilization Target: $27.95 (+3.6%)
PE Expansion Potential: +3.6%
Share & Embed Analysis

Found this analysis useful? Share it with your community or embed the live chart on your blog.

Tweet Reddit
bloggers & journalists: you are free to use our charts with attribution.
Last updated: June 23, 2026 2:15 PM ET
Data refreshes hourly during market hours. Next update: 3:15 PM
🔥 Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
7
Sells
Net
INSIDERS SELLING
Recent Transactions
Neil Harris Blumenthal SELL 22442 shares 2026-04-20
Neil Harris Blumenthal SELL 75213 shares 2026-04-17
Neil Harris Blumenthal SELL 2345 shares 2026-04-16

Unlock Insider Activity

See real-time buying/selling by company executives for WRBY.

Create Free Account

Already have an account? Log In

Top Rated Medical Instruments & Supplies Stocks

Top-rated stocks in Medical Instruments & Supplies by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
ISRG
Intuitive Surgical Inc
BUY
33 analysts
$565 57 HOLD
ALC
Alcon AG
STRONG BUY
27 analysts
$88 54 HOLD
RMD
ResMed Inc
BUY
19 analysts
$262 62 BUY
RGEN
Repligen Corporation
STRONG BUY
19 analysts
$176 50 HOLD
COO
The Cooper Companies, Inc
BUY
19 analysts
$81 65 BUY

Advanced WRBY Option Strategies

Professional options setups generated by AI based on today's WRBY price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for WRBY

WRBY Technical Chart WRBY Price Prediction WRBY Earnings Date WRBY Investment Advisor WRBY Fair Price Analyzer WRBY Options Advisor WRBY Options Chain WRBY Options Analysis WRBY Competitors
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals